10.495 Molecular Design and Bioprocess Development of Immunotherapies
Examines challenges and opportunities for applying chemical engineering principles to address the growing global burden of infectious disease, including drug-resistant strains and neglected pathogens. Topics include a historical overview of vaccines and immunotherapies, the molecular design considerations for new immunotherapies and adjuvants, the economic challenges for process development and manufacturing of immunotherapies, and new technologies for designing and assessing therapies. Case studies to cover topics for specific diseases. Students taking graduate version complete additional assignments.
This class has 7.06 as a prerequisite.
10.495 will be offered this semester (Spring 2017). It is instructed by J. C. Love.
This class counts for a total of 9 credits.
© Copyright 2015 Yasyf Mohamedali